SHP-1 and SHP-2 inhibit subsequent T-cell receptor (TCR) signaling pathways exhibiting the negative effect of T cell proliferation and the generation of cytokines including IFN-γ and IL-2, which eventually results in immune evasion by tumor cells [11]. Here, IFNG is linked to neoplasm.